OMB#: 0925-0216
Expiration Date: xx/xxxx
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
|
|
|
|
|
Dear PHILIP WOLF, MD: |
|
|
|
The Institutional Review Board (IRB) has reviewed the above referenced protocol and has determined that it meets the requirements set forth by the IRB and is hereby approved. This protocol is valid through the date indicated above. |
|
|
|
Revisions have been reviewed and approved as of 4/17/09. |
|
|
|
|
|
The
study may not continue after the approval period without
additional IRB review and approval for continuation. You will
receive an email renewal reminder notice prior to study
expiration; however, it is your responsibility to assure that this
study is not conducted beyond the expiration date. |
|
|
|
|
|
Sincerely yours, |
|
|
|
|
|
|
|
DANIELLE DELOSH |
|
IRB Board Member |
File Type | text/rtf |
File Title | Human Approval Letter |
Author | Greta Lee Splansky |
Last Modified By | curriem |
File Modified | 2010-11-29 |
File Created | 2010-11-29 |